Why Individual Stock Selection Will Be Key For Biotech Investors In 2021 – And RBC’s 15 Top Ideas

When it comes to biotech investing in 2021, healthcare stock analysts at RBC advised in a recent report that “Many pandemic-related influences are setting up the sector for outperformance but several factors could still work against the group, making individual stock selection a key priority…” With this in mind, those same analysts have shared their 15 top biotech stock ideas for 2021, comprised of large-cap, mid-cap and small-cap names. For these 15 stocks and what the analysts have to say about each, CLICK HERE.